Vaccine Adoption

COVID-19 Vaccine Adoption Study

 

Jeremy Greenberg shares an article from his company’s website that examines the findings from a study on the challenges of the COVID-19 vaccine adoption.

STUDY HIGHLIGHTS:

  • Half of participants say they are likely to take the COVID-19 vaccine as soon as it is available
  • Safety and minimizing side effects are the most important factors driving decisions
  • Two thirds of those not likely to take the vaccine doubt its safety
  • Women are more often the gatekeepers for households and are less likely to take the vaccine than men
  • Over one third of doctors and nurses are not yet supportive of taking a COVID-19 vaccine
  • Some do not consider their doctor’s recommendation important and are leery of new vaccines
  • President-elect Joe Biden’s victory had a net positive impact on vaccination adoption

Several pharmaceutical companies have made significant progress in the development of a COVID-19 vaccine, and are planning distribution for high priority segments of the U.S. population beginning in the next few weeks. While this is exciting news, it will take some time before a vaccine will be available for the general public – optimistically by April to June, 2021, according to Dr. Anthony Fauci.

 

The findings reported include:

  • Low expected adoption rates
  • The confidence gap
  • Women as the gatekeepers

 

Read the full article, New Study Identifies Challenges for COVID-19 Vaccine Adoption, on Avegroup.com.